Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
Clinical trial NCT00708721 · TERMINATED
Trial details
- NCT number
- NCT00708721
- Sponsor
- University of Utah
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2014-11-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.